MAIN PATHWAYS AND HOTSPOTS OF THE SPREAD OF THE SARS-COV-2 XFG ("STRATUS") STRAIN

Authors

  • Universal Publisher PhD in Medical Sciences, Associate Professor of the Department of Microbiology, Virology and Immunology, Urgench State Medical Institute, Urgench, Uzbekistan
  • Khudayberganova Kamola Tadjibayevna Assistant at the Department of Microbiology, Virology and Immunology, Urgench State Medical Institute, Urgench, Uzbekistan
  • Dinaliyeva Dina Maratovna Assistant at the Department of Microbiology, Virology and Immunology, Urgench State Medical Institute,

Keywords:

SARS-CoV-2; XFG (

Abstract

The aim of this work is to describe the probable transmission routes and typical foci of the SARS-CoV-2 Omicron subvariant XFG ("Stratus"), based on data regarding its antigenic and virological properties and in comparison with other variants (Alpha, Delta, Omicron). It is shown that XFG, which exhibits pronounced immune evasion with a slightly reduced affinity for ACE2, relies on the same dominant transmission mechanisms as other Omicron subvariants: airborne and aerosol pathways in conditions of close indoor contact [1,3,4,13].

References

1. Carabelli, A.M., Peacock, T.P., Thorne, L.G. et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev

Microbiol 21, 162–177 (2023). https://doi.org/10.1038/s41579-022-00841-7

2. Duschanov, B. A., Zakirov, Sh. Yu., Sadullayev, O. K., & Samandarova, B. S. (2023). ON THE NEW "OMICRON" CORONAVIRUS STRAIN.

3. Alexandra Popa et al. ,Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission

properties of SARS-CoV-2.Sci. Transl. Med.12,eabe2555(2020). DOI:10.1126/scitranslmed.abe2555

4. Chakraborty C et al. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS CoV 2 Variants. mBio. 2021. 12:10.1128/mbio.01140-21. https://doi.org/10.1128/mbio.01140-21

5. Dantas, A.C.S., Oliveira, H.B.M., Pereira, T.T.S. et al. Analysis of the prevalence, spread, and mutation patterns of SARS-CoV-2 variants: data from COVID-19 testing expansion strategy study in salvador, Northeast Brazil. Sci Rep 15, 31866 (2025). https://doi.org/10.1038/s41598-025-17691-x

6. Samandarova, B.S., Zakirov, Sh.Yu., Mengliyeva, B.B., Zokirova, M.Sh. (2023). Antiparasitic Immunity and COVID-19. Republican Scientific and Practical Conference on "Current Problems in Microbiology".

7. Lyu, L., Gill, M., Stott, G., Subedi, S., Dailey, C., Veytsel, G., Alabady, M., Fujimoto, K., Penn, R., Brown, P., Sealy, R., & Bahl, J. (2025).

Tracing SARS-CoV-2 clusters across local scales using genomic data.

Proceedings of the National Academy of Sciences of the

United States of America, 122(32), e2501435122. https://doi.org/10.1073/pnas.2501435122

8. Zakirov, Sh.Yu., Samandarova, B.S., Menglieva, B.B., & Zokirova, M.Sh. (2023). Features of the new "Omicron" coronavirus strain and the "Stealth-Omicron" subvariant. Proceedings of the Republican Scientific and Practical Conference on "Current Problems of Microbiology."

9. von Rotz, M., Kuehl, R., Durovic, A., Zingg, S., Apitz, A., Wegner, F., Seth-Smith, H. M. B., Roloff, T., Leuzinger, K., Hirsch, H. H., Kuster, S., Battegay, M., Mariani, L., Schaeren, S., Bassetti, S., Banderet-Uglioni, F., Egli, A., & Tschudin-Sutter, S. (2023). A systematic outbreak investigation of SARS-CoV-2 transmission clusters in a tertiary academic care center. Antimicrobial resistance and infection control, 12(1), 38. https://doi.org/10.1186/s13756-023-01242-y

10. Rader, T. S., 4th, Srinivasa, V. R., Griffith, M. P., Waggle, K., Pless, L., Chung, A., Wagester, S., Harrison, L. H., & Snyder, G. M. (2024). The utility of whole-genome sequencing to inform epidemiologic investigations of SARS-CoV-2 clusters in acute-care hospitals. Infection control and hospital epidemiology, 45(2), 144–149. https://doi.org/10.1017/ice.2023.274

11. Guo, C., Yu, Y., Liu, J., Jian, F., Yang, S., Song, W., Yu, L., Shao, F., & Cao, Y. (2025). Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1. The Lancet. Infectious

diseases, 25(7), e374–e377. https://doi.org/10.1016/S1473-3099(25)00308-1

12. Alhamlan, F. S., & Al-Qahtani, A. A. (2025). SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies. International journal of molecular sciences, 26(3), 1263. https://doi.org/10.3390/ijms26031263

13. Skums, P., Kirpich, A., Baykal, P. I., Zelikovsky, A., & Chowell, G. (2020). Global transmission network of SARS-CoV-2: from outbreak to pandemic. medRxiv : the preprint server for health sciences, 2020.03.22.20041145. https://doi.org/10.1101/2020.03.22.20041145

14. Chen, Z., Deng, X., Fang, L., Sun, K., Wu, Y., Che, T., Zou, J., Cai, J., Liu, H., Wang, Y., Wang, T., Tian, Y., Zheng, N., Yan, X., Sun, R., Xu, X., Zhou, X., Ge, S., Liang, Y., Yi, L., … Yu, H. (2022). Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study. The Lancet

regional health. Western Pacific, 29, 100592. https://doi.org/10.1016/j.lanwpc.2022.100592

15. Zakirov, Sh.Yu., & Samandarova, B.S. (2021). Contagiousness and resistance of the most dangerous COVID-19 strains. In Materials of the Republican Scientific and Practical Conference "Current Problems of Clinical and Sanitary Microbiology," dedicated to the 60th anniversary of the microbiologist and immunologist, Doctor of Medical Sciences, Professor Nuraliev N.A. Materials of the Republican Scientific and Practical Conference.

16. Volz E. (2023). Fitness, growth and transmissibility of SARS-CoV-2 genetic variants. Nature reviews. Genetics, 24(10), 724–734. https://doi.org/10.1038/s41576-023-00610-z

17. Guo, Z., Chen, Y., Liu, H., Xiao, G., Yu, D., Zhang, Z., Yang, Y., Yin, Z., & Zhang, H. (2025). Quantitatively analyzing the relationship between non-pharmaceutical interventions and the direction of virus evolution using a dynamic model. Frontiers in public health, 13, 1542759. https://doi.org/10.3389/fpubh.2025.1542759

18. Zakirov, Sh. Yu., & Samandarova, B. S. (2021). The most dangerous strains of COVID-19 in relation to antibodies. In Current problems of pharmacology and pharmacotherapy: Materials of the Republican scientific and practical conference.

19. Samandarova, B. S., Allaberganova, Z. S., & Zakirov, Sh. Yu. (2021). Nonspecific Prophylaxis of COVID-19. Current Issues in Morphology

Related to the COVID-19 Pandemic. Proceedings of the

International Scientific and Practical Conference.

20. San, J. E., Ngcapu, S., Kanzi, A. M., Tegally, H., Fonseca, V., Giandhari, J., Wilkinson, E., Nelson, C. W., Smidt, W., Kiran, A. M., Chimukangara, B., Pillay, S., Singh, L., Fish, M., Gazy, I., Martin, D. P., Khanyile, K., Lessells, R., & de Oliveira, T. (2021). Transmission dynamics of SARS-CoV-2 within-host diversity in two major hospital outbreaks in South Africa.

Virus evolution, 7(1), veab041. https://doi.org/10.1093/ve/veab041

21. Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021). The biological and clinical significance of emerging SARS-CoV-2 variants. Nature reviews.

Genetics, 22(12), 757–773. https://doi.org/10.1038/s41576-021-00408-x

22. Yang, X., Dong, N., Chan, E. W., & Chen, S. (2020). Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries. Emerging microbes &

infections, 9(1), 1287–1299. https://doi.org/10.1080/22221751.2020.1773745

23. Lythgoe, K. A., Hall, M., Ferretti, L., de Cesare, M., MacIntyre-Cockett, G., Trebes, A., Andersson, M., Otecko, N., Wise, E. L., Moore, N., Lynch, J., Kidd, S., Cortes, N., Mori, M., Williams, R., Vernet, G., Justice, A., Green, A., Nicholls, S. M., Ansari, M. A., … Golubchik, T. (2021). SARS-CoV-2 within-host diversity and transmission. Science (New York,

N.Y.), 372(6539), eabg0821. https://doi.org/10.1126/science.abg0821

24. Haanappel, C. P., Oude Munnink, B. B., Sikkema, R. S., Voor In 't Holt, A. F., de Jager, H., de Boever, R., Koene, H. H. H. T., Boter, M., Chestakova, I. V., van der Linden, A., Molenkamp, R., Osbak, K. K., Arcilla, M. S., Vos, M. C., Koopmans, M. P. G., & Severin, J. A. (2023). Combining epidemiological data and whole genome sequencing to understand SARS-CoV-2 transmission dynamics in a large tertiary care hospital during the first COVID-19 wave in The Netherlands focusing on healthcare workers. Antimicrobial resistance and

infection control, 12(1), 46. https://doi.org/10.1186/s13756-023-01247-7

25. Guo, C., Yu, Y., Liu, J., Jian, F., Yang, S., Song, W., Yu, L., Shao, F., & Cao, Y. (2025). Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1. The Lancet. Infectious

diseases, 25(7), e374–e377. https://doi.org/10.1016/S1473-3099(25)00308-1

26. Zakirov, Sh. Yu., Samandarova, B. S., & Allaberganova, Z. S. (2021). Pregnancy and Covid-19. In Current issues in pharmacology and pharmacotherapy: Proceedings of the Republican scientific and practical conference.

27. Leclerc, Q. J., Fuller, N. M., Knight, L. E., CMMID COVID-19 Working Group, Funk, S., & Knight, G. M. (2020). What settings have been linked to SARS-CoV-2 transmission clusters?. Wellcome open research, 5, 83. https://doi.org/10.12688/wellcomeopenres.15889.2

Downloads

Published

2026-03-11

How to Cite

MAIN PATHWAYS AND HOTSPOTS OF THE SPREAD OF THE SARS-COV-2 XFG ("STRATUS") STRAIN. (2026). ACUMEN: INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH, 3(3), 109-121. https://universalpublishings.com/index.php/aijmr/article/view/17097